COVID-19:
Vaccine advances and takeaways for 2022

We strive to provide individuals with disabilities equal access to our website. If you would like information about this content we will be happy to work with you. Please email us at: McKinsey_Website_Accessibility@mckinsey.com

The disruptive potential of some of the novel platforms that have come out of COVID-19 may open the door for more interest and innovation in this space.

Jennifer Heller McKinsey partner, Chicago

Featured interactive

Interactive

COVID-19 vaccine distribution

Explore the global rollout of COVID-19 vaccinations in comparison to the impact of cases.
This content is provided “as is” solely for informational purposes. It is not legal, health, or safety advice. Organizations should engage their own experts to ensure any adopted measures are compliant with applicable laws and standards in their jurisdictions. The opinions expressed by individuals or organizations are their own and do not reflect the views or opinions of McKinsey & Company. References to specific products or organizations do not constitute any endorsement or recommendation by McKinsey.